(Q34365432)

English

Randomized, multicenter trial to assess the efficacy, safety and tolerability of a single dose of a novel AMPA receptor antagonist BGG492 for the treatment of acute migraine attacks

scientific article

Statements

Randomized, multicenter trial to assess the efficacy, safety and tolerability of a single dose of a novel AMPA receptor antagonist BGG492 for the treatment of acute migraine attacks (English)
Baltazar Gomez-Mancilla
BGG492 Study Group

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit